Background: The Canadian Network for Mood and Anxiety Treatments (CANMAT)
conducted a revision of the 2009 guidelines by updating the evidence and …

To achieve the desired therapeutic objective, the drug product must deliver the active drug at
an optimal rate and amount. By proper biopharmaceutic design, the rate and extent of drug …

Depression is a common and severe neuropsychiatric disorder that is one of the leading
causes of global disease burden. Although various anti-depressants are currently available …

Although monoaminergic antidepressants revolutionized the treatment of Major Depressive
Disorder (MDD) over a half-century ago, approximately one third of depressed patients …

Background. Depression is one of the greatest health concerns affecting 350 million people
globally. Aromatherapy is a popular CAM intervention chosen by people with depression …

Purpose In our present study, a rat depression model induced by 6 weeks of chronic
unpredictable mild stress (CUMS) was established, and we investigated how Xiaoyaosan …

Background Depression is a severe neuropsychiatric disorder that affects more than 264
million people worldwide. The efficacy of conventional antidepressants are barely adequate …

Mind–body approaches are commonly used to treat a variety of chronic health conditions,
including depression and anxiety. A substantial proportion of individuals with depression …

Objective The aim of this research was to perform a systematic review to identify all
randomized controlled trials (RCTs) evaluating the efficacy and safety of add‐on celecoxib …

A saúde mental (SM) dos estudantes do ensino superior (EES) é importante para o seu
desenvolvimento e sucesso académico. A transição para o ensino superior configura uma …